Dr J. Mario Molina Calls for Controlling Growing Medicaid Costs

Specialty drug costs represent a huge concern for Medicaid, which already represents the second largest budget in a state, J. Mario Molina, MD, president and chief executive officer of Molina Healthcare, said in October at the National Conferences on Medicare and Medicaid, and Dual Eligibles Summit held by America’s Health Insurance Plans.

If Medicaid costs are not kept under control, states run the risk of the program’s growing budget cutting into other needed services, he explained.

“The funny thing is the government is willing to set pricing, especially on Medicare, for hospital services and physician services, but they’ve been unwilling to tackle pharmaceuticals,” Dr Molina said.